We are live on ! Find out more
SC

Slotnik Capital Portfolio holdings

AUM $342M
1-Year Est. Return 105.92%
This Fund
S&P 500
This Quarter Est. Return
+20.09%
1 Year Est. Return
+105.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$342M
AUM Growth
-$87.5M
Cap. Flow
-$108M
Cap. Flow %
-31.46%
Top 10 Hldgs %
70.82%
Holding
50
New
18
Increased
4
Reduced
3
Closed
23

Sector Composition

Rank Sector Weight
1 Healthcare 36%
2 Industrials 17.24%
3 Communication Services 14.7%
4 Consumer Staples 8.31%
5 Financials 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTLS
1
DELISTED
Chart Industries
GTLS
$45.9M 13.41%
221,811
+117,031
+112% +$24.2M
MASI
2
DELISTED
Masimo
MASI
$42.7M 12.5%
+240,300
New +$37.7M
PEN icon
3
Penumbra
PEN
$12.6B
$33.2M 9.7%
+101,000
New +$34.2M
TERN
4
DELISTED
Terns Pharmaceuticals
TERN
$22.2M 6.49%
+420,700
New +$17.3M
LBRDA icon
5
Liberty Broadband Class A
LBRDA
$4.42B
$21.1M 6.18%
420,700
+157,000
+60% +$7.9M
WBS icon
6
Webster Financial
WBS
$12.5B
$18.9M 5.52%
+272,000
New +$18.6M
WBD icon
7
Warner Bros
WBD
$63.4B
$16.2M 4.73%
588,308
-276,692
-32% -$7.75M
KVUE icon
8
Kenvue
KVUE
$37.4B
$14.8M 4.34%
860,156
+710,156
+473% +$12.6M
SLAB icon
9
Silicon Laboratories
SLAB
$7.17B
$13.6M 3.99%
+65,500
New +$12M
ACLX
10
DELISTED
Arcellx
ACLX
$13.5M 3.96%
+118,000
New +$10.4M
ARIS
11
Aris Mining
ARIS
$3.07B
$13M 3.8%
+700,116
New +$13.2M
LBRDK icon
12
Liberty Broadband Class C
LBRDK
$4.44B
$13M 3.79%
257,824
-102,700
-28% -$5.18M
TPH
13
DELISTED
Tri Pointe Homes
TPH
$12.3M 3.6%
+263,338
New +$10.7M
WES icon
14
Western Midstream Partners
WES
$19.3B
$10.8M 3.16%
262,614
AVO icon
15
Mission Produce
AVO
$1.12B
$10.5M 3.08%
+765,088
New +$10.2M
UNF icon
16
Unifirst Corp
UNF
$5.38B
$8.68M 2.54%
+34,500
New +$7.96M
APLS
17
DELISTED
Apellis Pharmaceuticals
APLS
$5.43M 1.59%
+135,000
New +$2.91M
NSC icon
18
Norfolk Southern
NSC
$77.1B
$4.39M 1.29%
15,311
-34,500
-69% -$10.3M
TWO
19
Two Harbors Investment
TWO
$1.27B
$3.71M 1.09%
+325,000
New +$3.64M
DAWN
20
DELISTED
Day One Biopharmaceuticals
DAWN
$3.58M 1.05%
+166,837
New +$2.35M
LWAY icon
21
Lifeway Foods
LWAY
$466M
$3.05M 0.89%
157,473
+28,892
+22% +$615K
AVO icon
22
CALL
Mission Produce
AVO
$1.12B
$2.75M 0.8%
+200,000
New +$2.66M
VAL icon
23
Valaris
VAL
$5.43B
$2.45M 0.72%
+25,000
New +$1.95M
RNA
24
Atrium Therapeutics
RNA
$198M
$2.42M 0.71%
+180,945
New +$2.54M
AVO icon
25
PUT
Mission Produce
AVO
$1.12B
$2.06M 0.6%
+150,000
New +$2M

Similar funds

Slotnik Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Slotnik Capital held 50 positions worth $342M, down 20% from $429M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Slotnik Capital withdrew a net $108M in Q1 2026, closing 23 positions and reducing 3 holdings. Its most notable exit was Avidity Biosciences, an estimated $51.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 24% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Slotnik Capital opened a new position in Masimo worth $42.7M.

  • Slotnik Capital's largest Q1 2026 buy was Masimo: 240,300 shares worth $42.7M.
  • Slotnik Capital added most to Chart Industries in Q1 2026, an estimated $24.2M increase.
  • Slotnik Capital's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $10.3M.
  • Slotnik Capital fully exited Avidity Biosciences in Q1 2026, selling an estimated $51.6M.
  • Slotnik Capital's ten largest holdings make up 71% of its $342M portfolio in Q1 2026.
  • Slotnik Capital opened 18 new positions and closed 23 in Q1 2026.
  • Slotnik Capital's portfolio value fell 20% quarter-over-quarter to $342M.

Based on Slotnik Capital's 13F filing for Q1 2026, filed 15 May 2026.